Ethyl N,N-dimethylaminomethylene acetoacetate, 97.0%, 100g

3-Fluoro-2-methoxybenzoic acid, 98.0%, 10g

2,7-Dibromospiro[fluorene-9,9'-xanthene], 97%, 5g

2-METHANESULFONYL-3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE, 90.0%, 1g

N4,N4,N4',N4'-Tetramethyl-[2,2'-bipyridine]-4,4'-diamine, 97%, 100mg

(4S,4'S)-2,2'-(Cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 250mg

(Z)-N-(1-Chloro-3-oxo-3-(piperidin-1-yl)-1-(o-tolyl)prop-1-en-2-yl)benzamide, 95.0%, 250mg

4-Methanesulfonylacetophenone, 98.0%, 100g

Tamiz molecular 3, polvo, 30 µm, 250 g, envase de vidrio

3,3-BIS(BROMOMETHYL)-3,4-DIHYDRO-2H-THIENO[3,4-B][1,4]DIOXEPINE, 95%, 5g

(2-Methyl-4-(trifluoromethyl)thiazol-5-yl)methanamine, 97.0%, 1g

Trimethyl 2,2':6',2''-Terpyridine-4,4',4''-tricarboxylate>96.0%(HPLC)200mg

2,6-Difluoroanisole, 98.0%, 1g